Burdie65 schreef op 27 februari 2018 21:09:
[...]
Dank je LOWER.., de 1e link gaf bij mij ook een error echter via een omwegje toch de informatie kunnen vinden.
(Zie hieronder)
Study: Drug costs for hereditary angioedema tripled in 2 years
April 15, 2015
source_formu_22.jpg
Patients with hereditary angioedema (HAE) are accruing specialty drug treatment costs of more than $300,000 annually on average, according to a
study presented at the Academy of Managed Care Pharmacy (AMCP) 27th Annual Meeting and Expo, in San Diego.
HAE is a rare genetic disorder that results in potentially life-threatening edema or swelling of limbs, abdomen, face, tongue or larynx—affects about 20 in 1 million Americans and still fewer commercially insured members.
According to the study, by pharmacy benefit manager Prime Therapeutics LLC (Prime), those costs tripled in the last 2 years. Prime recommended programs to help people with HAE and their health plans manage their condition to help improve care and reduce the growing cost of HAE care.